
Lonza Group AG – SIX:LONN.SW
Lonza Group AG stock price today
Lonza Group AG stock price monthly change
Lonza Group AG stock price quarterly change
Lonza Group AG stock price yearly change
Lonza Group AG key metrics
Market Cap | 36.62B |
Enterprise value | 39.43B |
P/E | 67.00 |
EV/Sales | 5.88 |
EV/EBITDA | 21.43 |
Price/Sales | 5.53 |
Price/Book | 4.10 |
PEG ratio | 9.22 |
EPS | 25.29 |
Revenue | 12.94B |
EBITDA | 4.07B |
Income | 1.87B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 8.56% |
Oper. margin | 18.46% |
Gross margin | 29.21% |
EBIT margin | 18.46% |
EBITDA margin | 31.46% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLonza Group AG stock price history
Lonza Group AG stock forecast
Lonza Group AG financial statements
Jun 2022 | 2.98B | 496M | 16.63% |
---|---|---|---|
Dec 2022 | 3.24B | 723M | 22.31% |
Jun 2023 | 3.07B | 410M | 13.32% |
Dec 2023 | 3.63B | 244M | 6.71% |
2025 | 7.62B | 1.10B | 14.43% |
---|---|---|---|
2026 | 8.54B | 1.35B | 15.9% |
2027 | 9.78B | 1.75B | 17.94% |
2028 | 10.99B | 2.11B | 19.26% |
Analysts Price target
Financials & Ratios estimates
2024-01-26 | 8.13 | 7.45 |
---|---|---|
2024-07-25 | 5.65 | 7.81 |
Payout ratio | 50.44% |
---|
2019 | 0.78% |
---|---|
2020 | 0.48% |
2021 | 0.4% |
2022 | 0.66% |
2023 | 1% |
Jun 2022 | 16743000000 | 6.65B | 39.76% |
---|---|---|---|
Dec 2022 | 17356000000 | 6.69B | 38.55% |
Jun 2023 | 17672000000 | 7.30B | 41.32% |
Dec 2023 | 17083000000 | 7.57B | 44.32% |
Jun 2022 | 300M | -177M | -180M |
---|---|---|---|
Dec 2022 | 726M | -802M | -105M |
Jun 2023 | 385M | -452M | 430M |
Dec 2023 | 1.03B | -674M | -583M |
Lonza Group AG alternative data
Aug 2023 | 17,494 |
---|---|
Sep 2023 | 17,896 |
Oct 2023 | 17,896 |
Nov 2023 | 17,896 |
Dec 2023 | 17,896 |
Jan 2024 | 17,896 |
Feb 2024 | 18,000 |
Mar 2024 | 18,000 |
Apr 2024 | 18,000 |
May 2024 | 18,000 |
Jun 2024 | 18,000 |
Jul 2024 | 18,000 |
Lonza Group AG other data
Insider | Compensation |
---|---|
Dr. Pierre-Alain Ruffieux Ph.D. (1969) Chief Executive Officer | $1,110,000 |
-
What's the price of Lonza Group AG stock today?
One share of Lonza Group AG stock can currently be purchased for approximately $749.2.
-
When is Lonza Group AG's next earnings date?
Unfortunately, Lonza Group AG's (LONN.SW) next earnings date is currently unknown.
-
Does Lonza Group AG pay dividends?
Yes, Lonza Group AG pays dividends and its trailing 12-month yield is 0.74% with 50% payout ratio. The last Lonza Group AG stock dividend of $0 was paid on 6 Sep 2025.
-
How much money does Lonza Group AG make?
Lonza Group AG has a market capitalization of 36.62B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.94% to 6.72B US dollars. Lonza Group AG earned 654M US dollars in net income (profit) last year or $7.81 on an earnings per share basis.
-
What is Lonza Group AG's stock symbol?
Lonza Group AG is traded on the SIX under the ticker symbol "LONN.SW".
-
What is Lonza Group AG's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Lonza Group AG?
Shares of Lonza Group AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Lonza Group AG's key executives?
Lonza Group AG's management team includes the following people:
- Dr. Pierre-Alain Ruffieux Ph.D. Chief Executive Officer(age: 56, pay: $1,110,000)
-
How many employees does Lonza Group AG have?
As Jul 2024, Lonza Group AG employs 18,000 workers.
-
When Lonza Group AG went public?
Lonza Group AG is publicly traded company for more then 25 years since IPO on 1 Nov 1999.
-
What is Lonza Group AG's official website?
The official website for Lonza Group AG is lonza.com.
-
How can i contact Lonza Group AG?
Lonza Group AG can be reached via phone at +41 61 316 81 11.
Lonza Group AG company profile:

Lonza Group AG
lonza.comSIX
17,834
Medical - Diagnostics & Research
Healthcare
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Basel, 4002
:
ISIN: CH0013841017
: